Table 2.
Strain number | Commercial bacteriophage cocktails |
||||
---|---|---|---|---|---|
Pyo |
|||||
Before adaptation | After adaptation | Intesti | Ses | Enko | |
39 | CL | CL | CL | OL | OL |
7 | IP | IP | IP | OL | OL |
20 | IP | OL | IP | OL | OL |
6,16 | IP | SCL | IP | OL | OL |
9 | OL | CL | OL | OL | OL |
1 | OL | CL | OL | SCL | OL |
23 | OL | OL | CL | OL | OL |
12,21,33 | OL | OL | OL | CL | CL |
31 | OL | OL | OL | IP | SCL |
4,8,14,24,26,30,34 | OL | OL | OL | OL | OL |
40 | OL | OL | OL | SCL | OL |
28 | OL | OL | SCL | CL | CL |
27,32 | OL | OL | SCL | SCL | SCL |
17 | OL | OL | SCL | OL | OL |
38 | OL | SCL | CL | SCL | SCL |
19 | OL | SCL | OL | OL | OL |
3 | R | CL | OL | IP | OL |
18,36,37 | R | CL | OL | OL | OL |
25 | R | CL | R | R | OL |
15 | R | CL | R | SCL | OL |
22 | R | CL | R | SCL | SCL |
2 | R | CL | SCL | SCL | CL |
5 | R | IP | R | R | R |
10 | R | IP | SCL | SCL | SCL |
11 | R | R | R | OL | SCL |
35 | R | R | R | R | R |
41 | R | R | SCL | SCL | CL |
29 | R | SCL | R | R | R |
13 | SCL | SCL | SCL | CL | CL |
Lytic activity | 65.9% | 92.7% | 82.9% | 90.2% | 92.7% |
CL, confluent lysis; SCL, semi-confluent lysis; OL, overgrown lysis; IP, individual plaques; R, resistant. Twenty-nine unique bacteriophage resistance/sensitivity profiles can be distinguished.